Mylotarg
Drug - Mylotarg
The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Gemtuzumab Ozogamicin
Multiple ingredients are in alphabetical order.
Strength -
5MG/VIAL
The potency of the active ingredient(s), Gemtuzumab Ozogamicin. May repeat for multiple part products.
Applicant -
WYETH PHARMS INC
The firm name holding legal responsibility for Mylotarg. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
021174
The FDA assigned number to Mylotarg. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Mylotarg. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
May 17, 2000
The date Mylotarg was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
Yes
The pioneer or innovator of Mylotarg. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Mylotarg is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Wyeth Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Mylotarg.
Mylotarg
|
